/neuro/taxonomy/term/330/all en /neuro/article/open-science-research/new-open-science-tool-studying-als-breathing-failure Protocol might also be used to study other motor neuron diseases, including spinal muscular atrophy and Kennedy’s disease.  Tue, 28 May 2024 14:43:16 +0000 Shawn Hayward 6046 at /neuro /neuro/article/patients/als-month-profile-daniele-doucet Danièle Doucet navigates diagnosis with help from family and friends. Tue, 28 May 2024 14:58:25 +0000 Shawn Hayward 6048 at /neuro /neuro/article/patients-giving-stories/aprilia-and-sienas-lemonade-stand-als Children’s initiative raises $8,600 for research into neurodegenerative disease. Fri, 08 Sep 2023 14:19:31 +0000 Sonia La Para 5795 at /neuro /neuro/article/research-patient-care/driving-care-±«ÓãÖ±²¥ The ALS team uses an innovative initiative to promote and prolong safe driving Wed, 12 Jul 2023 16:23:42 +0000 Sophie Lorenzo 5760 at /neuro /neuro/channels/news/multiple-als-projects-neuro-awarded-funding-328575 <p><b>Program brings together multidisciplinary teams with expertise in various areas of neurodegenerative disease</b></p> <p> </p> <p>Researchers at The Neuro (Montreal Neurological Institute-Hospital) make up a large part of eight projects funded by ALS Canada and the Brain Canada Foundation as part of their 2020 Discovery Grant Program, which brings together multidisciplinary research teams with expertise in various areas of ALS and neurodegenerative diseases to investigate critical areas of disease processes and clinical care.</p> Mon, 15 Feb 2021 15:24:42 +0000 shawn.hayward@mcgill.ca 4890 at /neuro /neuro/channels/news/mni-forms-promising-open-science-partnership-takeda-283212 <h2>Industry and academia team up for the benefit of people suffering from ALS</h2> <p>A unique industry-academia partnership will increase the rate at which promising drug compounds can be tested as potential treatments for amyotrophic lateral sclerosis (ALS), a disease with no known cure that affects 200,000 people worldwide.</p> <p>The partnership between The Montreal Neurological Institute and Hospital (MNI) and Takeda Pharmaceutical Company Limited (Takeda) will allow compounds developed by Takeda scientists to be tested on cell lines produced at the MNI.</p> Mon, 04 Dec 2017 17:46:14 +0000 shawn.hayward@mcgill.ca 2856 at /neuro /neuro/article/patients-research/als-care-and-research-time-covid-19 <p>Despite the COVID-19 pandemic, ALS patient care and research carries on at The Neuro with drug trials, a redesigned clinic, and a new approach for patients to maintain quality of life through mindfulness. Amyotrophic lateral sclerosis (ALS) affects about 3,000 Canadians. It is a neurodegenerative disease that is usually fatal within five years of diagnosis.</p> Thu, 18 Jun 2020 14:39:54 +0000 Victor Swoboda 4637 at /neuro /neuro/channels/news/neuro-create-worlds-first-als-phase-1-clinical-trial-unit-268803 <h2>The Tenaquip Foundation donation will allow for faster drug development, better care for ALS patients</h2> <p> </p> <p>A generous donation by The Tenaquip Foundation will improve the quality of care available to ALS patients at The Neuro, and increase the rate at which researchers can evaluate new ALS drugs.</p> Mon, 03 Jul 2017 19:07:21 +0000 shawn.hayward@mcgill.ca 2677 at /neuro /neuro/channels/news/als-fostering-awareness-devastating-disease-268478 <p>ALS takes away the patient’s motor functions one at a time, and the progress of finding effective drugs to counter its insidious effects has been slow. June is ALS Month, a good time to update the public on the latest developments in ALS research taking place at The Neuro.</p> <p>The Montreal Neurological Institute and Hospital (The Neuro) is recognized as a leading Canadian centre for research into amyotrophic lateral sclerosis (ALS) as well as for its care of ALS patients.</p> Fri, 02 Jun 2017 14:59:25 +0000 shawn.hayward@mcgill.ca 2634 at /neuro /neuro/channels/news/als-awareness-month-june-253218 <p>As a major Canadian centre for amyotrophic lateral sclerosis (ALS) research and treatment, the Montreal Neurological Institute and Hospital - The Neuro, invites the public and the media to learn more about the disease and current research and treatments, to donate money for ALS research and to wear the national emblem of ALS in Canada, the blue cornflower, during ALS Awareness Month in June.</p> Tue, 02 Jun 2015 14:36:53 +0000 anita.kar@mcgill.ca 1500 at /neuro /neuro/ALS-Month-2016 <p>The Neuro is recognized as a major Canadian center for ALS research and patient care. During June, designated ALS Month, The Neuro redoubles its efforts to inform the public and the media about amyotrophic lateral sclerosis (ALS), and urges all to help support ALS research.</p> Fri, 10 Jun 2016 20:45:35 +0000 shawn.hayward@mcgill.ca 2101 at /neuro /neuro/channels/news/improving-research-more-effective-antibodies-301680 <p><strong>Scientists demonstrate flaws in protein detection tools, and outline a solution</strong> </p> <p>A new study points to the need for better antibody validation, and outlines a process that other labs can use to make sure the antibodies they work with function properly.</p> <p>Antibodies are used in laboratories and clinics to study proteins, which are the biomolecules that translate information from an organism’s genes into the structure, function, and regulation of its tissues and organs. Genetic mutations can cause protein imbalances or malfunctions, leading to human disease.</p> Tue, 15 Oct 2019 16:03:40 +0000 shawn.hayward@mcgill.ca 4052 at /neuro /neuro/article/research/era-hope-als-research The Neuro’s ALS clinical trials are at peak levels Mon, 10 Jun 2019 14:43:36 +0000 Victor Swoboda 3851 at /neuro